PHE study shows COVID-19 vaccines highly effective in most people in at-risk groups

PHE study shows COVID-19 vaccines highly effective in most people in at-risk groups

A study from Public Health England (PHE), including more than 1 million people in at-risk groups, has demonstrated that COVID-19 vaccines are as effective...
REACT study shows COVID-19 infection rates three times lower for double vaccinated people

REACT study shows COVID-19 infection rates three times lower for double vaccinated people

Interim findings from the latest report of REACT-1, one of the country’s largest studies into COVID-19 infections in England, have been published by Imperial...
Booster COVID-19 vaccine clinical trial launches

Harnessing clinical trial data post-COVID

A survey has found that post-COVID, ambitious digital transformation strategies are seen as a wise investment as life sciences organisations upgrade their capacities for...
Scientists develop 'game-changing' COVID-19 antibody test

Scientists develop ‘game-changing’ COVID-19 antibody tests

Antibody tests that can detect whether people have been exposed to new variants of COVID-19 have been developed by the University of Aberdeen, in...
Novavax COVID-19 vaccine demonstrates 90% overall efficacy

Novavax COVID-19 vaccine demonstrates 90% overall efficacy

Novavax has announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, has demonstrated 100% protection against moderate and severe disease and 90.4% efficacy overall. Study...
PHE confirms coronavirus Delta variant is now dominant in the UK

PHE confirms coronavirus Delta variant is now dominant in the UK

The weekly coronavirus update released by Public Health England (PHE) has shown that cases of the Delta (VOC-21APR-02) variant in the UK have risen...
PHE study shows vaccine efficacy against B.1.617.2 variant after two doses

PHE study shows vaccine efficacy against B.1.617.2 variant after two doses  

A new study by Public Health England (PHE) has shown that two doses of the COVID-19 vaccines are highly effective against the B.1.617.2 variant...
Booster COVID-19 vaccine clinical trial launches

Booster COVID-19 vaccine clinical trial launches

Thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial launching today, Health and Social Care Secretary, Matt Hancock has...
Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GlaxoSmithKline (GSK) have reported positive interim Phase II clinical trial safety and immunogenicity data for Medicago’s plant-derived COVID-19 vaccine candidate, which has...
Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722...

Latest articles

Career close-up: Alessandra Dorigo

Career close-up: Alessandra Dorigo

Pf talks to Alessandra Dorigo, who was recently appointed General Manager UK, Ireland, Baltics and Nordics at Advanced Accelerator Applications (AAA), a Novartis company. Tell...
JCVI advises that all UK 16- and 17-year-olds should be offered COVID-19 vaccine

JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
OPEN Health acquires medical communications agency Spirit

OPEN Health acquires medical communications agency Spirit

OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...

Popular articles

MHRA approves first immunotherapy treatment for mesothelioma

MHRA approves first immunotherapy treatment for mesothelioma   

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the combination of nivolumab plus ipilimumab for the first-line treatment of adult patients with...
Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Challenges in recruiting during the pandemic

Challenges in recruiting during the pandemic

Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve patient outcomes. The partnership...
OPEN Health acquires medical communications agency Spirit

OPEN Health acquires medical communications agency Spirit

OPEN Health has announced the acquisition of North West UK-based medical communications agency Spirit. A statement from OPEN Health stated that integrating the Spirit business...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription